Congress trades and big insider sales, sent the day they're filed. Free.
Open in TelegramOfficers, directors and 10% owners must report trades within two business days on SEC Form 4. INSIDER parses each filing's XML from EDGAR. By default only discretionary open-market purchases and sales are shown; grants, option exercises and tax withholding are one click away.
| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 38 | Employees' Retirement System of the State of Hawaii10% Owner | NALafayette Square USA, Inc. Open-market purchase | BUY | $4.00M 270.6K sh |
| Mar 31, 2026 traded Mar 30, 2026 |
| 37 | Vanzura ElisabethDirector, CMO | Open-market purchase | BUY | $5,655 1,500 sh | Mar 31, 2026 traded Mar 30, 2026 |
| 37 | Stenberg JonDirector, President & CEO | Open-market purchase | BUY | $235K 50.0K sh | Mar 31, 2026 traded Mar 30, 2026 |
| 36 | Dunn RickChief Financial Officer | Open-market purchase | BUY | $99K 16.7K sh | Mar 31, 2026 traded Mar 27, 2026 |
| 36 | McDowell Erin WSVP & General Counsel | Open-market sale | SELL | $396K 8,250 sh | Mar 31, 2026 traded Mar 27, 2026 |
| 35 | Manor SagitCFO | Open-market sale | SELL | $69K 1,252 sh | Mar 31, 2026 traded Mar 31, 2026 |
| 35 | Szabo ShandellDirector | Open-market sale | SELL | $375K 11.7K sh | Mar 31, 2026 traded Mar 30, 2026 |
| 33 | Huang Michael F.Sr. VP of Clinical Development | Open-market sale | SELL | $128K 4,256 sh | Mar 31, 2026 traded Mar 27, 2026 |
| 33 | Manning MeredithChief Commercial Officer | Open-market sale | SELL | $146K 4,864 sh | Mar 31, 2026 traded Mar 27, 2026 |
| 33 | Eleftheriou KaterinaDirector | Open-market purchase | BUY | $982 65 sh | Mar 31, 2026 traded Mar 27, 2026 |
| 32 | Dunn RickChief Financial Officer | Open-market purchase | BUY | $98K 19.1K sh | Mar 31, 2026 traded Mar 30, 2026 |
| 32 | Furman Carly LisanneCEO NAYX North America | Open-market sale | SELL | $17K 313 sh | Mar 31, 2026 traded Mar 31, 2026 |
| 32 | Tepper OrenCRO | Open-market sale | SELL | $3,991 74 sh | Mar 31, 2026 traded Mar 30, 2026 |
| 30 | Garagic DenisCHIEF TECHNOLOGY OFFICER | Open-market sale | SELL | $84K 15.1K sh | Mar 31, 2026 traded Mar 30, 2026 |
| 29 | Manning MeredithChief Commercial Officer | Open-market sale | SELL | $65K 2,100 sh | Mar 31, 2026 traded Mar 27, 2026 |
| 29 | Goel Rajeev K.Director, CHIEF EXECUTIVE OFFICER, 10% Owner | Open-market sale · 10b5-1 plan | SELL | $356K 44.0K sh | Mar 31, 2026 traded Mar 30, 2026 |
| 29 | Huang Michael F.Sr. VP of Clinical Development | Open-market sale | SELL | $57K 1,838 sh | Mar 31, 2026 traded Mar 27, 2026 |
| 27 | Sonne StephenCHIEF LEGAL OFFICER | Open-market sale | SELL | $19K 3,471 sh | Mar 31, 2026 traded Mar 30, 2026 |
| 27 | Thatcher TrevorCHIEF FINANCIAL OFFICER | Open-market sale | SELL | $17K 3,030 sh | Mar 31, 2026 traded Mar 30, 2026 |
| 26 | Huang Michael F.Sr. VP of Clinical Development | Open-market sale | SELL | $15K 488 sh | Mar 31, 2026 traded Mar 27, 2026 |
| 26 | Manning MeredithChief Commercial Officer | Open-market sale | SELL | $18K 558 sh | Mar 31, 2026 traded Mar 27, 2026 |
| 26 | Lentell EricChief Legal & Strategy Officer | Open-market sale · 10b5-1 plan | SELL | $268K 50.0K sh | Mar 31, 2026 traded Mar 26, 2026 |
| 25 | Hoffmann MartinCEO | Option exercise | M | $936K 25.0K sh | Mar 31, 2026 traded Mar 20, 2026 |
| 25 | Bimes Randy S.Director | Open-market purchase | BUY | $10,000 263 sh | Mar 31, 2026 traded Mar 27, 2026 |
| 25 | Tirman MatthewPresident | Open-market sale | SELL | $49K 9,499 sh | Mar 31, 2026 traded Mar 30, 2026 |
| 24 | Ugwumba Chidozie10% Owner | Open-market sale | SELL | $332K 68.0K sh | Mar 31, 2026 traded Mar 31, 2026 |
| 24 | Guerrero Paula LChief Information Officer | Small acquisition | L | $995 177 sh | Mar 31, 2026 traded Jan 30, 2026 |
| 22 | Peyovich Daniel SPresident & CEO | Tax withholding | F | $2.69M 7,862 sh | Mar 31, 2026 traded Mar 30, 2026 |
| 22 | Degner DennisChief Executive Officer & Pres | Grant or award | A | $3.64M 76.3K sh | Mar 31, 2026 traded Mar 27, 2026 |
| 22 | Lamattina John LDirector | Option exercise | M | $247K 2,161 sh | Mar 31, 2026 traded Mar 6, 2026 |
| 22 | Scucchi MarkEVP & CFO | Grant or award | A | $2.41M 50.6K sh | Mar 31, 2026 traded Mar 27, 2026 |
| 22 | Urness Ryan FSVP, GC & Secretary | Tax withholding | F | $1.52M 4,440 sh | Mar 31, 2026 traded Mar 30, 2026 |
| 21 | Conklin Jeffery P.CFO & Treasurer | Option exercise | M | — 12.5K sh | Mar 31, 2026 traded Mar 28, 2026 |
| 21 | Truex SamanthaDirector | Option exercise | M | — 3,166 sh | Mar 31, 2026 traded Mar 28, 2026 |
| 21 | Truex SamanthaDirector | Option exercise | M | — 3,166 sh | Mar 31, 2026 traded Mar 28, 2026 |
| 21 | Kantoff AaronDirector | Option exercise | M | — 3,166 sh | Mar 31, 2026 traded Mar 28, 2026 |
| 21 | Lozinski Jeffrey William10% Owner | Open-market sale | SELL | $3,000 100.0K sh | Mar 31, 2026 traded Mar 30, 2026 |
| 21 | Sullivan Christopher RyanChief Financial Officer | Option exercise | M | — 24.2K sh | Mar 31, 2026 traded Mar 28, 2026 |
| 21 | Preston Tracy MEVP, CLO & Corporate Secretary | Option exercise | M | — 7,504 sh | Mar 31, 2026 traded Mar 28, 2026 |
| 21 | Lewis Bryon MatthewChief Operations Officer | Option exercise | M | — 2,587 sh | Mar 31, 2026 traded Mar 28, 2026 |